Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 

New acceleration techniques will :
reduce scan times 
cause artifacts 
increase expenses 
be useful if you have a lot of experience 
doesn't do much 
never heard of 




 
MRI News Service:
'European Medicines Agency'
SEARCH NEWS FOR   
 
Result: Searchterm 'European Medicines Agency' found in 6 news
Result Pages
More Results: Database  (3)  
News     News Refinements:  Contrast Agents  Devices  Financial  
European regulators suspend use of MRI drugs, but why hasn't the FDA?
''''after a year-long review, the European Medicines Agency last month suspended three contrast agents used in MRI scans over concerns they contain a potentially toxic metal that can be ...'
Wednesday, 2 August 2017   by www.statnews.com
EMA's final opinion confirms restrictions on use of linear gadolinium agents in body scans
''''The European Medicines Agency (EMA) has concluded its review of gadolinium contrast agents, confirming recommendations to restrict the use of some linear gadolinium agents used in MRI body scans ...'
Friday, 21 July 2017   by www.ema.europa.eu
GE Health asks EMA to reconsider proposal to stop sale of MRI drug
''''General Electric Co's healthcare business said it had requested the European Medicines Agency to reconsider the recommendation made by its panel to suspend the marketing authorization of ...'
Wednesday, 16 March 2016   by whtc.com
AMAG Pharmaceuticals and Takeda Announce Acceptance of Submission of Feraheme® Marketing Authorization Application to the European Medicines Agency
''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and Takeda Pharmaceutical Company Limited (TSE: 4502) today provided a regulatory and clinical update for Feraheme® (ferumoxytol) Injection for intravenous (IV) use. On June 1, 2010, AMAG submitted a ...'
Tuesday, 29 June 2010   by www.snl.com
European Medicines Agency makes recommendations to minimise risk of nephrogenic systemic fibrosis with gadolinium-containing contrast agents
''''The European Medicines Agency (EMEA) has adopted a set of recommendations aimed at minimising the risk of nephrogenic systemic fibrosis (NSF) with gadolinium-containing contrast agents in patients at risk of developing the ...'
Friday, 20 November 2009   by www.ema.europa.eu
Guerbet withdraws its European Marketing Authorisation Application for Sinerem
''''Authorisation Application (MAA) for Sinerem, a new contrast agent for MRI. The Sinerem MAA had been submitted to the EMEA (European Medicines Agency) in November 2006 for the detection and characterisation of metastatic lymph nodes in pelvic ...'
Saturday, 13 December 2008   by www.prnewswire.co.uk
News     News Refinements:  Contrast Agents  Devices  Financial  
Radiology News Open this link in a new window Ultrasound Imaging News Open this link in a new window
Result Pages
It seemed the world was divided into good and bad people. The good ones slept better... while the bad ones seemed to enjoy the waking hours much more.
- Woody Allen
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 21 November 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]